HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Share-based Compensation (2018 - 2021)

HUTCHMED (China)'s (HMDCF) quarterly Share-based Compensation came in at $5.0 million in Q2 2021, up 87.03% year-over-year from $2.7 million in Q2 2020, and up 68.83% quarter-over-quarter from $2.9 million in Q1 2021.

Analysis

HUTCHMED (China) (HMDCF) Share-based Compensation (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Share-based Compensation for 4 consecutive years, with $5.0 million the latest figure, recorded in Q2 2021.

  • On a quarterly basis, Share-based Compensation rose 87.03% year-over-year to $5.0 million in Q2 2021; TTM through Jun 2021 was $10.9 million, a 80.62% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, down 18.12% from the prior year.
  • Share-based Compensation was $5.0 million for Q2 2021 at HUTCHMED (China), up from $2.9 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $5.0 million in Q2 2021 and troughed at $334000.0 in Q1 2018.
  • A 4-year average of $2.2 million and a median of $2.3 million in 2018 frame the typical range for Share-based Compensation.
  • Across the five-year window, Share-based Compensation sank 84.97% in 2020 and jumped 754.49% in 2021, its largest moves.
  • Over 4 years, Share-based Compensation stood at $2.8 million in 2018, then sank by 36.52% to $1.8 million in 2019, then surged by 51.11% to $2.7 million in 2020, then surged by 87.03% to $5.0 million in 2021.
  • The last three Share-based Compensation figures came in at $5.0 million (Q2 2021), $2.9 million (Q1 2021), and $2.7 million (Q2 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Amgen 212.20 Bn 198.21 Bn 7.24 Bn 247.00 Mn
2 Gilead Sciences 181.83 Bn 178.65 Bn 6.22 Bn 231.00 Mn
3 Vertex Pharmaceuticals 132.47 Bn 124.61 Bn 2.84 Bn 108.10 Mn
4 Regeneron Pharmaceuticals 82.56 Bn 74.56 Bn 3.93 Bn 243.00 Mn
5 Argenx Se 61.59 Bn 56.40 Bn 1.37 Bn -
6 Moderna 54.65 Bn 49.51 Bn 52.00 Mn 120.00 Mn
7 Alnylam Pharmaceuticals 34.13 Bn 30.82 Bn 992.69 Mn 86.63 Mn
8 Biogen 31.42 Bn 30.13 Bn 1.96 Bn 77.40 Mn
9 Roivant Sciences 30.21 Bn 30.21 Bn 1.16 Mn 83.34 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 4.98 Mn
Mar 31, 2021 2.95 Mn
Jun 30, 2020 2.66 Mn
Mar 31, 2020 345,000.00
Dec 31, 2019 1.76 Mn
Sep 30, 2019 1.29 Mn
Jun 30, 2019 1.83 Mn
Mar 31, 2019 2.30 Mn
Dec 31, 2018 2.77 Mn
Sep 30, 2018 2.34 Mn
Jun 30, 2018 2.46 Mn
Mar 31, 2018 334,000.00